R&D Collaborations

CDA signed between CSIR-IIIM, Jammu and M/s VerGo Pharma Research Laboratories PVT. LTD at 1st Floor, Keni Building, Dr. Dada Vaidya Road, Panji, GOA on January 22nd, 2016.

Umbrella agreement signed between  CSIR-Indian Institute of Integrative Medicine  and Emami Ltd., 687, Anandapur, EM Bypass, Kolkata on January 22nd, 2016.

Agreement signed between  CSIR- IIIM, Jammu  and Sarvotham Care Ltd., 1-20-248, Umajay Complex, 1st Floor, Rasoolpura, Secunderabad on January 13th, 2016.

CDA signed between IIIM, Jammu and Emami Ltd., its registered Office at 687, Anandapur, EM Bypass, Kolkata-70107 on November 18th, 2015.

Agreement for engagement of CSIR-IIIM, Jammu , National Institute of Medicinal Materials (NIMM) and National Hospital of Traditional Hospital Medicine (NHTM) of the Vietnam on October 26th, 2015.

Agreement signed between CSIR-IIIM and Medicinal and Aromatic plants Research Production (Radha Rani Trust) on October 23rd, 2015.

Agreement for Seeking Intellectual Property rights signed between CSIR and  National Biodiversity Authority on October 23rd, 2015.

CDA signed between CSIR-IIIM and Sarvotham Care Ltd., Umajay Complex, Rasoolpura, Secundrabad. (Dated October 23, 2015) on October 14th, 2015.

Non Disclosure and Confidentiality agreement signed between IIIM, Jammu and Nagarjuna Fertilisers and Chemicals Ltd.,  Hyderabad on August 17th, 2015.

Bipartite memorandum of agreement signed with Mayor Infrastructure Pvt. Ltd., New Delhi and Indian Institute of Integrative Medicine, Jammu on August 17th, 2015.

Bipartite memorandum of agreement signed with Biotech Consortium India Ltd., New Delhi and IIIM-Jammu on August 17th, 2015.

Agreement signed between CSIR-IIIM and National Research Development Corp. (NRDC), Anusandhan  Vikas, 20-22, Zamroodpur Community Centre  Kailash  Colony Extension, New Delhi. on August 13th, 2015.

Agreement signed between  CSIR and Hindustan Phosphates Pvt. Ltd. on May 18th, 2015.

MOU signed between CSIR-IIIM and DE Montfort University, The Gateway Leicester, LE1 9BH, UK on April 1st, 2015.

MOU signed between CSIR-IIIM and The University of Louisiana at MONROE, USA on April 1st, 2015.

Memorandum of agreement signed between CSIR- IIIM, Jammu and VVF (India) Ltd., Mumbai on February 23rd, 2015.

Confidential agreement signed between Sphaera Pharma Research and Development Pvt. Ltd., and IIIM Jammu on January 8th, 2015.

MoU has been signed by IIIM, Jammu with Shri Mata Vaishno Devi University, Jammu on 8th March, 2005 wherein IIIM, Jammu will help the SMVDU to start B.Tech in Industrial Bio-Technology, the first such course to be taught any where in the country. Under this the students of this course will have access to the state-of-the-art facilities available at IIIM, Jammu and also get an opportunity to interact with the scientists and visiting faculty from IIIM.

MoU has been signed between IIIM, Jammu and Flex Foods Ltd., Dehradun on 16th July, 2004 for undertaking Toxicity studies as per USFDA/OECD Guidelines and preclinical studies on a herbal formulation as a dietary / food supplement for sexual behaviour changes.

Agreement signed between DST, New Delhi, IIIM, Jammu, Ayurvedic Research Center-KEM Hospital, Mumbai, TN Medical College , Mumbai, M/S Dhootpapeshwar Ltd., Mumbai in June, 2004 for the “ Development of herbomineral and plant based disease oriented immunomodulatory formulations”. Tripartite agreement signed between DST, New Delhi, IIIM, Jammu and Indian Medicines Pharmaceuticals Corp. Ltd., Mohan (Almora) on 24th June, 2004 for the “Standardization of Ayurvedic herbal formulations using modern techniques.

Under confidential disclosure agreement signed between IIIM, Jammu and M/S Bicon Ltd., Bangalore on 22 January, 2004, IIIM will disclose Intellectual property in the area of herbal drugs to the party for entering into a joint venture for the development of herbal drugs or formulations thereof.

Under an Mou signed between IIIM, Jammu and M/S Prathista Industries Ltd., Secundrabad on 21 August, 2003, IIIM will develop technologies for the production of Gluconate salts of Cu(II) & Fe(II), glucono-delta lectone and Calcium lectobionate for the party.

A Tripartite Mou has been signed between IIIM, Jammu, M/S Medley Pharmaceutical Ltd., Mumbai and Center for Liver Research and Diagnostics, Hyderabad on 14th July, 2003. Under this agreement the organizations would work in collaboration for generation of pharmacological data of a product of plant origin i.e. 97– M developed by IIIM for treatment of liver disorders.

Under an MoU signed between IIIM, Jammu and M/S Genova Bio-techniques Pvt. Ltd., Hyderabad, on 10th April, 2003 IIIM, Jammu had to undertake “Up-scaling and standardizing the Process for the Production of the enriched extract of 1,25-dihydroxy Vitamin D3 from Cestrum diurnum at 10 Kg Raw material scale.

MOU between IIIM and Nicholas Primal India, Mumbai on for Development of production Technology of Hypericum perforatum, standardization of protocol and manufacturing processess for its value added products was signed on September 10, 2001.

With Chitarangan National Cancer Institute, Calcutta on 23rd July 2001 for evaluation of in vitro cytotoxicity of certain compounds against human cancer cell lines.

With M/s Shanta Biotech on 21st June, 2001 for development of recombinant homologue of IIIMY-15 enzyme as a commercial product directed to pharmaceutical Industry for resolution of racemic drug intermediates.

MOU signed between IIIM and International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi on June 2, 2001 for collaboration on (i) developing c-DNA and EST libraries from Withania somnifera and (ii) Identification of biologically important substances which are being produced by gall midge after infection in susceptible and resistant varieties of rice.

MOU signed between IIIM and Sher-e-Kashmir Institute of Agriculture & Technology , Srinagar on July 2, 2000 regarding mutual scientific & technical cooperation for strengthening the R & D programmes on cultivation of mushrooms, and some selected medicinal & aromatic plants.